India to United Kingdom: Salmeterol Export Trade Route

The India to United Kingdom Salmeterol corridor is one of India's established pharmaceutical export routes, with 26 shipments documented worth a combined $2.3M USD. The route is dominated by CIPLA LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's salmeterol manufacturing sector.

Across 6 active suppliers, the average shipment value stands at $89.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with salmeterol's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 27.4%, placing it at rank #4 among India's top salmeterol export destinations globally.

On the import side, key buyers of Indian salmeterol in United Kingdom include ALLOGA UK LTD, HEALTH CITY CAYMAN ISLANDS HCCI, THE MANAGER and 3 others. ALLOGA UK LTD is the single largest importer with 3 shipments valued at $2.3M USD.

India's salmeterol exports to United Kingdom are driven primarily by a handful of large-scale manufacturers. CIPLA LIMITED with 3 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 6 active exporters signals a competitive but concentrated market — buyers in United Kingdom benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — CIPLA LIMITED, NARAYANA HRUDAYALAYA LIMITED, DOSHI MEDICARE PRIVATE LTD — together account for 100% of total trade value on this route. The average shipment value of $89.9K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as salmeterol+fluticasone propionate-inhaler-25mcg+250mcg-seroflo synchrobreathe- and salmeterol+fluticasone propionate-inhaler-25mcg+250mcg-seroflo- sup document no:783979, suggesting that buyers in United Kingdom tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ALLOGA UK LTD is the largest importer with 3 shipments worth $2.3M USD — representing 100% of all salmeterol imports from India on this route. A total of 6 buyers are active on this corridor.